Showing results (341-350 of 551) with videos related to

Sort By:
Pageof 56
The Prostate|September 21, 2017
High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancerChristoph Burdelski, Rami Shihada, Andrea Hinsch, et al.
BMC Cancer|December 19, 2020
Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancerMorton Freytag, Martina Kluth, Elena Bady, et al.
International Journal of Cancer|March 10, 2020
Loss of the adhesion molecule CEACAM1 is associated with early biochemical recurrence in TMPRSS2:ERG fusion-positive prostate cancersAndreas M Luebke, Wiebke Ricken, Martina Kluth, et al.
Neoplasia (New York, N.Y.)|March 11, 2017
Overexpression of the A Disintegrin and Metalloproteinase ADAM15 is linked to a Small but Highly Aggressive Subset of Prostate CancersChristoph Burdelski, Michael Fitzner, Claudia Hube-Magg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
The Combination of DNA Ploidy Status and PTEN/6q15 Deletions Provides Strong and Independent Prognostic Information in Prostate CancerMaximilian Lennartz, Sarah Minner, Sophie Brasch, et al.
The Science of the Total Environment|January 15, 2026
Global drivers of variation in blood mercury of seabirds revealed by a meta-analysisJumpei Okado, Bungo Nishizawa, Johannes H Fischer, et al.
Water Research|November 16, 2024
Making Waves: A justice-centred framework for wastewater-based public health surveillanceMohammed Rafi Arefin, Carolyn Prouse, Josie Wittmer, et al.
World Journal of Urology|February 11, 2018
Immunohistochemically detected IDH1<sup>R132H</sup> mutation is rare and mostly heterogeneous in prostate cancerAndrea Hinsch, Meta Brolund, Claudia Hube-Magg, et al.
Carcinogenesis|November 3, 2016
Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancerWaldemar Wilczak, Semin Rashed, Claudia Hube-Magg, et al.
Disease Markers|June 14, 2019
Immune Exclusion Is Frequent in Small-Cell Carcinoma of the BladderTim Mandelkow, Niclas C Blessin, Eva Lueerss, et al.
Pageof 56